SWOG S0910: A Phase 2 Trial of Clofarabine/Cytarabine/Epratuzumab for Relapsed/Refractory Acute Lymphocytic Leukaemia

Precursor B-acute lymphoblastic leukaemias (pre-B ALLs) comprise the majority of ALLs and virtually all blasts express CD22 in the cytoplasm and on the cell surface. In the present study (Southwestern Oncology Group S0910), we evaluated the addition of epratuzumab, a humanized monoclonal antibody ag...

詳細記述

保存先:
書誌詳細
主要な著者: Advani, Anjali S., McDonough, Shannon, Coutre, Steven, Wood, Brent, Radich, Jerald, Mims, Martha, O’Donnell, Margaret, Elkins, Stephanie, Becker, Michael, Othus, Megan, Appelbaum, Frederick R.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209396/
https://ncbi.nlm.nih.gov/pubmed/24579885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12778
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料